Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Binge eating therapy may also improve diabetes control

NCT ID NCT06325670

Symptom relief Sponsor: Odense University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 12-session group therapy program for binge eating disorder could also improve blood sugar control in adults with type 2 diabetes. 34 participants received the therapy or were placed on a waitlist. Researchers measured changes in binge eating episodes and diabetes severity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cognitive behavioral therapy (group sessions)
What this could lead to
If successful, this approach could offer a way to reduce binge eating and improve diabetes management in people with both conditions.
What could go wrong
This was a small, completed study with only 34 participants, so results may not apply to everyone. The waitlist design also limits what can be concluded.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Feb 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with type 2 diabetes * A diagnosis of mild to severe BED based on thorough assessment * Sufficient ability to communicate in Danish * Ability to sit on a chair for up to 3 hours Exclusion Criteria: * Previously diagnosed with autism spectrum disorder or psychotic disorders * Dementia or developmental disability. * Severe anxiety or depression or personality disorder assessed through clinical interview with SCID (based on DSM-V criteria) * Currently experiencing severe to moderate substance abuse Use of weight loss medication is not an exclusion criterion but is clearly noted regarding the results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Binge-eating disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

binge eating disorder Binge-Eating Disorder diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Binge-eating disorder Diabetes mellitus type 2

Contacts and locations

Locations

  • Region Of Southern Denmark Locations

    Odense, Region Syddanmark, 5000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.